CVS Health (CVS) Tops Q3 EPS by 7c; Trims, Narrows FY16 EPS Outlook
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Forward Air (FWRD) Appoints Shawn Stewart as CEO
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
CVS Health Reports Third Quarter Results
November 8, 2016 6:55 AM ESTWOONSOCKET, R.I., Nov. 8, 2016 /PRNewswire/ --
Third Quarter Year-over-year Highlights:
Net revenues increased 15.5% to $44.6 billion GAAP operating profit increased 20.9% to $2.8 billion GAAP diluted EPS from continuing operations of $1.43 Adjusted EPS increased 28.0% to $1.64 GAAP and Adjusted EPS both include a benefit of approximately 5 cents per share related to a lower income tax rate primarily due to the resolution of tax matters previously forecasted for the fourth quarterYear-to-date Highlights:
Cash flow from operations of $7.9 billion Generated free... More